In another study, miR-181a-5p was shown to exert a direct regulatory effect on REL, NFKBIA (IκBα), and NFKB1, resulting in the repression of NF-κB signaling in DLBCL [101]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.